January 31, 2024 11:44 AM EST
Pharma
Manufacturing

Ther­mo Fish­er’s Q4 rev­enue dips due to ‘still mut­ed’ mar­ket

Anna Brown

News Reporter

Ther­mo Fish­er an­nounced on Wednes­day its rev­enue de­clined in the fourth quar­ter of 2023 com­pared to the year pri­or. The Swedish com­pa­ny saw a se­quen­tial …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

To lead NIH, Trump taps Stan­ford aca­d­e­m­ic and pan­dem­ic re­sponse crit­ic Jay Bhat­tacharya

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

Up­dat­ed: Am­gen obe­si­ty shot shows 20% weight loss, but dos­ing ques­tions hang over read­out

A service from the Financial Times